Log In
Print this Print this

HyperAcute Renal

  Manage Alerts
Collapse Summary General Information
Company NewLink Genetics Corp.
DescriptionAlpha 1,3-galactosyltransferase-expressing allogeneic renal tumor cell vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationRenal cancer
Indication DetailsTreat metastatic renal cell cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today